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by Linda S. Erdreich*
Epidemiologic data can be used in risk assessment in various ways: to calculate the
dose-response relationship between exposure levels and adverse effects; to establish
ranges of exposure known to be safe or unsafe; to verify an endpoint in humans derived
from a route or species extrapolation; to support assumptions necessary for performing
extrapolation procedures. These points areillustrated intherisk assessment forexposure
to asbestos in drinking water.
A previous risk assessment for asbestos, the EPA's Ambient Water Quality Criteria
(AWQC) for Asbestos, was derived from cohort studies ofinhalation exposure. Epidemio-
logic studies ofingested asbestos, all ofgeographical correlation design, were compared
on the basis oftheir ability to add information in support ofboth the route extrapolation
andlow-dose extrapolation usedinthis risk assessment. Results oftheseingestion studies
were inconsistent due to variable ability to detect a risk from chronic low-level exposure.
After preliminary comparisons offactors that determine scientific validity and statistical
power, two ingestion studies were selected to determine ifthey hadthe potential to detect
the risk predicted by the AWQC.
This evaluation has shown that these studies do not offer quantitative data for estimat-
ing levels associated with a defined risk. Due to short exposure duration and limited
power, clearly safe and clearly unsafe ranges could not be definitely identified. The most
appropriate ingestion studies suggest, but do not prove, the endpoint derived from the
route extrapolation in the AWQC.
Introduction
The incorporation ofinformation from epidemi-
ologic studies into health risk assessment de-
pends on the nature of the available scientific
data and the nature of the unresolved issues.
Epidemiologic data can be used in health risk
assessment for a variety of purposes. The process
ofscreening and comparing epidemiologic studies
for use in health risk assessment will be described
for ingested asbestos.
The EPA's Ambient Water Criterion (AWQC)
for Asbestos for human health is based on human
inhalation studies; therefore, data on the health
effects ofhuman exposure via ingestion are neces-
sary to verify this route extrapolation. Ingested
asbestos studies are evaluated to select those ap-
propriate for use in risk assessment. Central to
this evaluation is the comparison ofthe increased
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risk predicted on the basis ofthe AWQC with the
estimated ability of a given study to detect this
risk.
An integral aspect of screening studies for use
in risk estimation is the critical analysis ofall the
strengths and weaknesses of relevant aspects of
each study. Because Marsh, in his presentation at
this workshop (1), did this in great detail for the
epidemiologic studies of ingested asbestos, this
analysis will not be repeated here.
Background
One of EPA's many endeavors in the area of
health risk assessment has been the Ambient
Water Quality Criteria Documents (AWNQCD) (2).
The Clean Water Act of 1977 (P.L. 95-217) re-
quired these documents to calculate criteria for
65 toxic pollutants or pollutant categories and to
summarize and reflect accurately current knowl-
edge ofthe kindand extent ofall effects onhuman
health that would be expected from the presence
ofpollutants in ambient water. The water quality
criteria for human health are a scientific assess-L. S. ERDREICH
ment of ambient levels of a pollutant that is
estimated to result in defined levels of risk for a
given carcinogen or no-observed-adverse-effect
levels for toxicants. States may use these criteria
and, after considering local environmental condi-
tions and human exposure patterns, incorporate
them into regulations as standards.
Obviously, the ideal source ofdata for assessing
human risk is exposure situations in humans via
the appropriate exposure route. In the absence of
quantitative route-specific data for humans, it is
sometimes necessary to substitute either human
data from another route of exposure or dose-re-
sponse data in animals. Extrapolations from
route to route (e.g., inhalation to ingestion), from
animals to humans, or from high to low doses are
performed according to procedures documented in
the Federal Register (3). These procedures are
constantly being refined and apply to situations
in addition to those of ambient water quality-
hazardous waste sites, for example.
Basis of the Current AWQC for
Asbestos
The AWQC for asbestos is derived from expo-
sure-response data in three epidemiologic studies
involving large occupational cohorts exposed for a
working lifetime to airborne asbestos. These
workers, who were followed over time to ascer-
tain causes of death, were found to have an in-
creased incidence ofperitoneal mesothelioma and
gastrointestinal (GI) cancers. Intwo ofthe studies
used to calculate the criterion, GI cancers in-
cluded esophagus, stomach, small intestine, colon
and rectum. In the third study, liver, gallbladder
and pancreas were also included. The assumption
that these cancers can also be caused by ingested
asbestos was supported by positive associations
for digestive tract sites in the geographic correla-
tion study of ingested asbestos in the California
study first reported by Kanarek et al. (4). The
route extrapolation is also supported by the fact
that most ofthe inhaled asbestos is cleared from
the respiratory tract andingestedby normalbody
processes.
The average of the excess deaths in all three
cohorts exposed via inhalation was related to the
average exposure index. This average was also
extrapolated to low dose levels to estimate crite-
ria levels; e.g., the ambient water level necessary
to keep lifetime excess cancer risk to an exposed
population below 10-5 is 0.3 million fibers of all
sizes/L (0.3 MFL), assuming ingestion of2 L wa-
ter/day and 70 yr exposure (2). According to EPA
guidelines (3), the extrapolation to low dose is
linear when using human data and does not in-
clude calculation ofanupper 95% confidence limit
as when the extrapolation is calculated from ani-
mal data. Because both a route extrapolation and
a low-dose extrapolation were used, the criteria
would be strengthened by support from human
studies of exposure by ingestion at ambient lev-
els.
Uses of Epidemiologic Data in
Risk Assessment
Epidemiologic data can be used in risk assess-
ment for a variety ofpurposes: (1) to estimate the
dose-response relationship in orderto identify the
highest concentration level at which no adverse
health effects or a defined low-level of adverse
health effects are anticipated; (2) to establish
ranges ofexposures that are or are not associated
with an adverse effect; (3) to support or verify an
endpoint identified from a different route ofexpo-
sure or from experiments in animals; (4) to sup-
port general assumptions necessary for perform-
ing extrapolation procedures.
These purposes depend on characteristics ofthe
data as determined by study design, power, and
quality ofthe exposure data. For example, quan-
titative exposure-response data are necessary for
quantitative estimates described in points (1) and
(2). Studies with qualitative exposure data are
useful for point (3) to verify a route extrapolation
or a target organ for a suspected carcinogen. To
support extrapolation processes, point (4) usually
requires a body of evidence, such as the human
epidemiologic studies of carcinogens that corre-
late with animal studies.
The derivation of the existing asbestos AWQC
for human health from epidemiologic data illus-
trates point (1). That assessment required an
extrapolation from the inhalation exposure route
to the ingestion route because existing epidemio-
logic studies of ingested asbestos were of geo-
graphic correlation (ecological) design not appli-
cable for quantitative risk assessment.
Research on the health effects of asbestos has
continued since the publication ofthe AWQC and
has contributed information that can be used to
reevaluate this risk assessment. More recent
studies designed to evaluate the association be-
tween ingested asbestos and cancer canbe used to
address point (2), distinguishing safe from unsafe
ranges of exposure, and point (3), verifying the
association between ingested asbestos and cer-
tain cancers. Point (4) describes the use ofabroad
epidemiologic data base and is presented for com-
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pleteness, although data on asbestos cannot yet
be used for this purpose.
Comparing Epidemiological
Studies of Ingested Asbestos
All nine ingestion studies compared in this
discussion are ecological studies in which readily
accessible vital statistics, such as mortality or
incidence, are correlated with the exposures as-
sumed to be experienced by these populations.
Geographic correlation studies usually serve as
screening devices to indicate associations that
could be examined subsequently with more pre-
cise and powerful analytic designs, such as case
control or cohort. The correlation studies were
performed to offer a rapid and cost-efficient mech-
anism for addressing the public health questions
ofwhether areas with asbestos-cement pipe have
higher cancer rates. The nine studies cited (4-12),
which were performed in five geographic areas,
lack precision due to the possible misclassifica-
tions inherent to this study design in which resi-
dence in an area is assumed to reflect lifetime
exposure to that water supply. Inferences that can
be made are weak and insufficient for establish-
ing a causal relationship. These studies do, how-
ever, make it feasible to incorporate a sample size
sufficiently large to detect small increases in low-
probability outcomes such as cancer.
The limitations of these asbestos studies are
due in part to characteristics inherent to the
problem ofstudying the effects of low-level expo-
sures on rare outcomes such as cancer. Even at
the high occupational exposure levels, relative
risks formortality following inhalation exposures
ranged from 1.5 to 2.5 for GI sites (13). The
limitations listed in Table 1 suggest that, to es-
tablish the dose-response gradient by epidemio-
logic studies, an analytic (case-control or cohort)
study of sufficient sample size would be required
to detect the low relative risk expected.
This table also lists approaches to handle these
limitations. Many have been attempted in the
studies to date. For example, a surveillance sys-
tem has been initiated in Duluth to follow trends
over time (5), and studies were initiated in the
Puget Sound area, which has high ambient levels
(11). Confounding risk factors for cancer, such as
diet, smoking habits and occupational exposures,
are not well evaluated in geographic correlation
studies.
The evidence for a causal relationship between
a risk factor and disease is often evaluated by
comparing the pattern of results among studies.
Consistent and repeatable results to support the
association are particularly important when the
association is weak due to low exposure levels or
the low potency ofthe carcinogen. Table 2 shows
that few associations between asbestos and can-
cer are positive in both sexes, and few are re-
peated across studies for the same cancer site
(11). Two sites that show repeated positive associ-
ations among studies are the pancreas and stom-
ach, but the latter is not consistently positive for
both sexes. Since the AWQC was based on total
peritoneal mesotheliomas and "gastrointestinal
cancers," mainly ofesophagus, stomach, colon and
rectum, those sites must be examined together in
order to evaluate the AWQC. (Peritoneal me-
sothelioma is rare and was often omitted from the
studies because few cases were reported.)
Table 3 presents results for these sites, as re-
ported only in papers representing two of the
areas, Duluth and California (4-6,9). Mortality
data for Duluth reported for four 5-yr periods did
not support an increase, although the data were
tested for trend (5). Levy et al. (6) found that
standardized incidence ratios were higher for the
two comparison cities than for Duluth. Both re-
ports of cancer incidence in the San Francisco
area show an increase in rates with asbestos fiber
counts (4,9). Conforti et al., who tested the stand-
ardized incidence ratios for slope and found the
increase for "all digestive tract cancers" signifi-
cant for white males and for white females, inter-
Table 1. Inherent limitations ofstudies involving
ingested asbestos and possible solutions.
Inherent limitations Approaches
Exposure duration is short Increase observation period
compared to cancer's long Maintain surveillance over
latency period (5-8) time
Exposure levels are often Select study population from
low, particularly for high exposure area
asbestos-cement pipe (7, 8, Increase sample size
12)
Exposure to individuals is Design study to examine
not usually assessed in individual exposures
geographical correlation
studies (4-12)
Probability ofoutcome is Design study to focus on
low, requiring extremely high-risk groups
large samples Use case/control study
design to reduce required
sample size
Confounding factors exist Control by: stratification or
and can bias results mathematical modeling or
restriction ofstudy design
to certain areas or
individuals
101Table 2. Summary ofstudies ofcancer risk in relation to asbestos in water supply by site ofneoplasm.a
Site ofneoplasmb
Small
Area Reference Esophagus intestine Colon Rectum Stomach Pancreas Lungs Peritoneum
Duluth, MN Mason et al. (5) 00 - 00 MF MF OF
Levyetal. (6) 00 00 00 00 MO MF 00
Quebec Wigle (10) - 00 00 MO OF MO
Connecticut Harrington et al. (7) 00 00 00
Meigsetal. (8) 00 00 00 B 00
California Conforti et al. (9) MF 00 00 00 MF MF 00 OF
Kanerek et al. (4)c
Washington Polissar et al. (11) 00 MF 00 00 00 00 00
Florida Millette et al. (12) -00 00
aAdapted from Polissar et al. (11).
bM, association in males; F, association in females; B, association in both sexes combined; 0, no association; -, not studied.
cConforti et al. (9) update these results.
Table 3. Summary ofstudies that assessed the association between
all digestive cancers and exposure to asbestos.
All digestive Digestive tract Digestive-related organs
Area Reference (ICD 150-158)a,b (ICD 150-154) (ICD 155-158)
Duluth, MN Mason et al. (5) 00
Duluth, MN Levy et al. (6) 00
California Conforti et al. (9) MF MF MO
Florida Millette et al. (12) 00
aCode as in eighth revision. International Classification Disease, 1968 (16). 150-154: esophagus, stomach, small intestine, colon,
rectum. 155-158: liver, gallbladder, pancreas, retroperitoneum.
bM, association in males; F, association in females; 0, no association; -, not studied.
preted the findings as indicating a positive gradi-
ent with asbestos levels (9). These increases were
consistent when stratified on education and in-
come to control for the potential confounding ef-
fect ofsocioeconomic status.
The inconsistent results across these ingestion
studies can be interpreted by examining some
factors that affect the ability ofa study to detect
an association. Factors common to nearly all of
these studies include lack ofcontrol for confound-
ing riskfactors, possible misclassification ofexpo-
sure due to migration, and lack of assessment of
variability in daily water source. These factors
are inherent to geographic correlation studies
using residence as a surrogate for exposure. Fac-
tors that vary among the studies and affect the
power of the study to detect an increase include
the sample size, frequency of outcome, exposure
level, duration ofthe observation period, and du-
ration ofthe exposure.
Table 4 shows some ofthese factors for each of
the six areas covered by these nine studies. The
Canadian study was seriously biased by the con-
founding effect ofoccupational exposures (10). In
Minnesota, Florida, and Connecticut, duration is
barely equal to the suspected 20- to 40-yr latency
period for these cancers (13). Exposure levels are
low in Connecticut and Florida, thus weakening
the association. A lack of association in these
geographic areascouldbe attributed tothe inabil-
ity of those studies to detect low risks. The high
exposure levels and longer duration in Puget
Sound and California suggest that the size ofthe
association would be greater in these areas and
therefore more easily detectable.
The ability of a study to detect the risk esti-
mated by the AWQC can be assessed by compar-
ing the estimated excess risk with some measure
ofthe ability ofthe study to detect this risk. The
increased risk expected due to asbestos exposure
can be estimated by the number ofexcess cancer
cases predicted by the risk assessment in the
AWQC. Several assumptions are required to re-
late the AWQC-estimated 1 x 10-5 lifetime excess
risk for 0.3 MFL to the yearly incidence rate. On
assuming that all ages are equally at risk and
that the dose-response relationship is linear, an
approximation ofthe excess cancer risk per year
can be calculated for the California area as fol-
lows:
1 cancer 20 MFL
105 persons x 70-yr exposure 0.3 MFL
where 20 MFL is the middle value of the high
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Table 4. Characteristics ofthe epidemiologic studies that affect the power to detect an association.
Duration
Study area ofexposure, Population Probable Estimate ofmaximum excess
(reference) yr exposed exposure level cancer per yeara,b
Duluth, MN (6) =16-17 100,000 1-30 MFL
Connecticut (7, 8) =19 576,000 <0.1-0.7 MFL
Bay Area, CA (4, 9) >40 1,000,000 4-36 MFL 1 x 10-5
Puget Sound, WA (11) >50 78,000 200 MFL 10 x 10-5
Florida (12) >25 46,000 <1-10 MFL (AC pipe)
>25 87,000
Quebec (10) >50 140,000 80-220 MFL
C
aBasedonAWQCD estimate of1 x 10-5lifetime excessriskofgastrointestinal cancerandperitoneal mesotheliomafor0.3 MFL (1
MFL = 3.33 x 10-5 excess cancers) and on assumptions described in the text.
bCalculated only for areas with potential for lifetime exposure at time ofstudy: [1 cancer/(100,000 persons/70 yr)] (20 MFL/0.3
MFL) = 1 x 10-5.
CResults biased by occupational exposures in the exposed group.
exposure group. A similar extrapolation for the
Puget Sound, using 200 MFL, estimates an excess
rate ofGI cancers of 10 x 10-5. Assuming a back-
ground incidence rate of 90/100,000 (0.0009) for
California and 75/100,000 for Puget Sound for
these cancers, the estimated relative risk for ex-
posed groups is 1.01 for California and 1.1 for
Puget Sound. There are two other areas ofuncer-
tainty in these estimates. First, the average age
for the 1973 San Francisco-Oakland population
up to age 70 is 31 yr, representing average expo-
sure duration, whereas the AWQC is based on 70
yr exposure. This may understate the risk. Alter-
natively, using incidence instead of mortality
may overstate the risk because the incidence rate
for GI cancers is approximately twice the mortal-
ity rate.
The ability ofa study to detect a given risk is its
power. It is not appropriate to estimate power for
ecological study designs on the basis of sample
size alone because of the unquantifiable biases
introduced by misclassification. It is possible,
however, to determine whether these studies
would be at least large enough to detect a differ-
ence in the absence of systematic biases by com-
paring them to cohort studies of similar size for
which power can be estimated. A comparison will
be made with studies of cohort design because
analyses in these studies focus on exposed and
unexposedgroups (14). However, this exercise can
tell us only whether a study is too small; it cannot
help to determine ifthe sample size is adequate.
Sample size tables (14) show that for an out-
come of0.001, slightly higher than the incidence
of all GI cancers, a cohort sample the size ofthe
California study would have an 80% probability
ofdetecting a relative risk of 1.1 at a = 0.05. A
cohortsample ofthe size ofthePugetSoundstudy
would have an 80% probability of detecting a
relative risk of 1.5 at a = 0.05. The Puget Sound
study reported the results for single sites: a co-
hort study this size could detect a relative risk of
4 for pancreatic or stomach cancer. Ifthe risk for
these exposures is similarto that predicted bythe
AWQC, and ifthe assumptions apply, then these
correlation studies would probably be too small to
detect the expected risk.
While the study in Puget Sound (11) was inter-
preted to be negative, the 6-yr study in California
(9) suggests a positive association ofcancer ofthe
digestive system with ingestion ofasbestos. This
study need not be ignored simply because less
powerful studies do not verify this endpoint.
While the multiple statistical comparisons and
the ecological design introduce biases that reduce
the power, the high significance level of the test
fortrend suggests some association with asbestos.
The increase in "all digestive cancers"was signifi-
cant with a low relative risk (<1.1) and was
associated with the high exposure census tracts
(4-36 MFL). This study suggests that any associ-
ation between GI cancers and asbestos exposure
may be limited to specific sites such as the stom-
ach and pancreas. These are relatively rare can-
cer sites in humans and require large sample
sizes to detect an increase. Polissar et al. (11)
compared all of the studies and concluded that
results for pancreatic cancer were the least likely
to be due to chance (see Table 2). The case-control
study by Polissar et al. in the Puget Sound area
presented at this workshop (15) offers an opportu-
nity for similar analyses for specific sites. The
minimum risk that could be detected was under
2.0 foreach sexforthefollowinggroupedor single
sites: digestive system, colon, respiratory tract,
and lungs.
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Discussion
The observation that geographic correlation
studies ofpopulations exposed to ingested asbes-
tos detected little evidence for an increased can-
cerriskmustbe reevaluated inview ofthe consid-
erations affecting the power ofany study. Several
of the studies were insensitive due to low expo-
sure levels and short exposure duration. The po-
tential for misclassification in the ecological
study design makes it inappropriate to assess
power directly, yet negative studies should be
interpreted in terms of the risk each has the
ability to detect. The maximum sensitivity that
could be expected from the potentially valid stud-
ies, those performed in California (4,9) and Puget
Sound (11), leads to the conclusion that the abil-
ity to detect increased relative risks <2 (100%
increase) is questionable. It is possible to summa-
rize these two studies as follows: Little ifany risk
was detected in studies that were capable only of
detecting the increase in GI cancers if it was
greater than that predicted by the AWQC.
Summary
This body of evidence, summarized in view of
the general uses of epidemiolgoic data in health
risk assessment described above, does not offer
quantitative data for estimating levels associated
with a defined risk. Due to limited statistical
power and inherent biases in the study design,
clearly safe and clearly unsafe ranges cannot be
definitely identified. The results of the study in
the Bay Area by Conforti et al. (9) suggests, but
does not prove, the endpoint derived from the
route extrapolation required for the AWQC.
These ingestion studies do suggest that the risk is
not greater than that estimated from the inhala-
tion studies and may be less. Due to the large
number ofindividuals with potential lifetime ex-
posure to asbestos, even small increases in rela-
tive risks are important; therefore, measures to
reduce exposure are still indicated.
Tb resolve the issue ofthe human health risk of
waterborne asbestos, it would be necessary to
initiate analytic epidemiologic studies that have
greater sensitivity. Examination of available
pharmacokinetic and experimental animal data
would be useful. If data from animal studies
clearly did not support the association between
cancer and ingested asbestos, the need for human
studies might be circumvented.
The author thanks James R. Millette of the U.S. EPA for
suggesting the basis ofTable 4, and Dr. Rebecca H. Osborne of
the National Institute for Occupational Safety and Health for
suggestions.
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